Hypertrophic Cardiomyopathy and Sudden Death
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What is the risk of sudden death for patients with hypertrophic cardiomyopathy? Dr. Barry Maron, Director of the Hypertrophic Cardiomyopathy Center in Minneapolis, will discuss the risk of sudden death and the use of defibrillators in these high risk patients.
Overview
What is the risk of sudden death for patients with hypertrophic cardiomyopathy? Dr. Barry Maron, Director of the Hypertrophic Cardiomyopathy Center in Minneapolis, will discuss the risk of sudden death and the use of defibrillators in these high risk patients.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
Biomarkers of the Storm: Decoding IRI’s Signature
HF Management for Patients with Comorbid Conditions
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Personalizing Care Within the RCC Treatment Paradigm
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?